How to Get Losartan in Florida

What Is Losartan and Why Florida Patients Use It

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three distinct indications: hypertension in adults and pediatric patients aged 6 and older, reduction of stroke risk in hypertensive patients with left ventricular hypertrophy (LVH), and nephropathy in patients with type 2 diabetes and elevated serum creatinine [1]. It works by selectively blocking the AT1 receptor, preventing angiotensin II from raising vascular resistance and aldosterone secretion.

Florida has one of the highest rates of hypertension-related hospitalization in the southeastern United States, with the CDC reporting that 34.8% of Florida adults have been diagnosed with high blood pressure [2]. That prevalence makes ARBs among the most prescribed drug classes in the state.

The LIFE trial (Losartan Intervention For Endpoint Reduction in Hypertension, N=9,193) published in The Lancet in 2002 demonstrated that losartan 50 to 100 mg reduced the composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol over a mean follow-up of 4.8 years (P<0.001) [3]. In the diabetic nephropathy subgroup, the RENAAL trial (N=1,513) showed losartan 50 to 100 mg reduced the risk of doubling serum creatinine by 25% and end-stage renal disease by 28% compared with placebo at a mean follow-up of 3.4 years [4].

Those are not marginal numbers. They are why cardiology and nephrology guidelines treat losartan as a first-line option rather than a second-line fallback.

Who Can Prescribe Losartan in Florida

Any licensed prescriber in Florida with independent prescribing authority can write a losartan prescription. That group includes MDs, DOs, Advanced Practice Registered Nurses (APRNs) with a full practice authority designation, and Physician Assistants (PAs) operating under a supervising physician protocol.

Florida Statute §458.347 governs PA prescribing. PAs may prescribe all non-Schedule I drugs, including losartan, within the scope of their supervisory agreement [5]. APRNs practicing under §464.012 and holding certification in a relevant specialty (adult-gerontology primary care, family, or cardiovascular) may prescribe independently after completing a 3,000-hour supervised transition-to-practice period [6].

In practical terms: a telehealth visit with a certified family nurse practitioner or a PA working under a supervising cardiologist or internist is sufficient to receive a losartan prescription in Florida, provided the prescriber is licensed in the state and the visit meets the standard-of-care threshold for a synchronous evaluation.

The Florida Board of Medicine and the Board of Nursing both require that a valid patient-provider relationship be established before prescribing. A real-time audio-visual telehealth visit satisfies that requirement under §456.47 F.S. A text-only or asynchronous questionnaire alone does not [7].

How Florida Telehealth Laws Apply to Losartan Prescribing

Florida's telehealth statute (§456.47 F.S., enacted 2019, amended 2023) explicitly authorizes the prescribing of medications via synchronous telehealth visits for conditions that can be safely evaluated without an in-person physical exam [7]. Hypertension qualifies when the patient can provide a verified home blood pressure reading and answers a structured clinical history.

Providers must document the following before prescribing:

1. A contemporaneous blood pressure reading (self-reported or device-transmitted values from a validated cuff are acceptable under Florida telehealth guidance).
2. Confirmation that the patient has no active pregnancy (losartan carries an FDA Black Box Warning for fetal toxicity in the second and third trimesters) [1].
3. Review of current medications, specifically potassium-sparing diuretics, NSAIDs, and lithium, which interact meaningfully with ARBs.
4. A plan for baseline lab follow-up within 30 days of initiating therapy.

Prescribers who are licensed in another state but not Florida may NOT prescribe to Florida patients via telehealth unless they hold a Florida out-of-state telehealth registration under §456.47(4) F.S. [7]. Patients should confirm their telehealth provider holds either a full Florida license or a valid Florida telehealth registration before the consultation.

The HealthRX clinical team uses a four-checkpoint pre-prescription framework for losartan telehealth visits: (1) confirm indication with ICD-10 code documentation (I10 for hypertension, N08 for diabetic nephropathy, I50.2x for systolic heart failure), (2) screen for pregnancy and renal contraindications, (3) order a baseline BMP or CMP with a 30-day follow-up window, and (4) select the starting dose based on eGFR and baseline potassium. Patients with eGFR <30 mL/min/1.73m² or serum potassium above 5.0 mEq/L require additional clinical review before initiating.

What Labs Are Required Before Starting Losartan in Florida

A baseline metabolic panel is not optional. The 2023 ACC/AHA Hypertension Guideline and the JNC 8 panel both recommend checking serum electrolytes, creatinine, and eGFR before initiating any renin-angiotensin-aldosterone system (RAAS) blocker [8].

Why these labs matter:

Losartan reduces aldosterone secretion, which decreases potassium excretion. In patients with pre-existing renal impairment or concurrent use of potassium-sparing diuretics (spironolactone, triamterene, amiloride), this creates a meaningful risk of hyperkalemia. The ONTARGET trial (N=25,620) found that dual RAAS blockade with an ARB plus an ACE inhibitor doubled the rate of hyperkalemia requiring hospitalization without additional cardiovascular benefit [9]. That trial is one reason guidelines now restrict combination RAAS therapy.

Specific lab thresholds before initiating:

• Serum potassium: must be <5.0 mEq/L (proceed with caution 5.0 to 5.4 mEq/L; do not initiate if ≥5.5 mEq/L without nephrology input).
• eGFR: no absolute floor for hypertension, but dose adjustment is not required for renal impairment alone; hepatic impairment does require a lower starting dose of 25 mg [1].
• Serum creatinine: document baseline to detect acute kidney injury (AKI) at follow-up (a creatinine rise <30% above baseline within 2 weeks is expected and acceptable with RAAS blockade; >30% warrants dose reduction or discontinuation).

A complete metabolic panel (CMP) or basic metabolic panel (BMP) drawn within 90 days prior to initiation is generally accepted by Florida telehealth prescribers. Older labs may be acceptable for patients with a documented stable history, though individual prescribers set their own recency thresholds.

A urinalysis with microalbumin-to-creatinine ratio (UACR) is additionally required when the indication is diabetic nephropathy, per KDIGO 2022 guidelines [10].

Step-by-Step: Getting a Losartan Prescription in Florida

Step 1. Choose your visit type. In-person primary care, cardiology, or nephrology is appropriate for any patient with significant comorbidities. Telehealth is appropriate for otherwise healthy adults with uncomplicated hypertension who can document their blood pressure at home with a validated device.

Step 2. Gather your blood pressure data. Take readings on three separate mornings before the consultation, seated, after 5 minutes of rest, using the same arm. The average of those six readings (two per session) gives the prescriber a reliable baseline.

Step 3. Complete or arrange baseline labs. If you do not have a recent BMP/CMP, most telehealth platforms can order labs at a national draw site (LabCorp or Quest) before the prescription visit, or immediately after with a 30-day follow-up window.

Step 4. Complete the synchronous telehealth or in-person consult. The prescriber confirms indication, screens for contraindications (pregnancy, bilateral renal artery stenosis, prior angioedema with an ACE inhibitor or ARB, hyperkalemia), and selects the starting dose.

Step 5. Receive the prescription. Prescriptions for losartan are sent electronically (e-prescribing is standard in Florida). Generic losartan 50 mg once daily is the most common starting regimen. The prescriber may titrate to 100 mg at a 2 to 4 week follow-up visit if blood pressure remains above target (>130/80 mmHg per 2023 ACC/AHA guidelines) [8].

Step 6. Fill at a Florida-licensed pharmacy. Any Florida-licensed retail pharmacy (CVS, Walgreens, Publix, Winn-Dixie) or mail-order pharmacy licensed to ship to Florida can fill generic losartan. Cash prices range from $10 to $30 for a 30-day supply, and GoodRx coupons regularly place the 100-tablet supply under $15 at major chains.

Transferring an Existing Losartan Prescription to Florida

Patients relocating to Florida from another state can transfer a losartan prescription, with caveats.

Florida pharmacy law (§465.0276 F.S.) permits the transfer of a non-controlled prescription from another state to a Florida-licensed pharmacy one time per prescription [11]. The receiving Florida pharmacist contacts the originating out-of-state pharmacy to verify the original prescription details. Refills remaining on the original prescription transfer along with the record.

Practical limitations. Some out-of-state prescribers write prescriptions valid only in their licensed state. If the original prescription contains such a restriction, or if no refills remain, the transfer cannot proceed. In that case, a new Florida-based prescribing visit is required.

Patients on long-term losartan who are new to Florida should contact their current prescriber and their new Florida pharmacy simultaneously before the transfer. Most telehealth platforms can bridge the gap with a 30-day supply pending a new patient visit.

Medicaid patients should note that Florida Medicaid coverage for losartan depends on the indication documented on the prescription. As of 2025, losartan appears on the Florida Medicaid preferred drug list for hypertension and diabetic nephropathy (in patients with type 2 diabetes), but coverage parameters change; checking the current preferred drug list at the Agency for Health Care Administration (AHCA) website before the visit avoids delays.

Prior Authorization for Losartan in Florida

Most private insurers and Medicare Part D plans do not require prior authorization (PA) for generic losartan because it is a preferred generic on virtually every tier-1 formulary. However, brand-name Cozaar (the original Merck formulation) typically requires PA and step-therapy documentation demonstrating that the generic was tried first.

When PA is required, Florida providers typically submit the following documentation:

• Diagnosis code (ICD-10) confirming a covered indication.
• Most recent blood pressure measurements or nephropathy lab values.
• Documentation of any previous antihypertensive therapy tried and failed (for brand-name requests).
• Clinical notes establishing the patient-provider relationship.

The insurer is required under Florida law (§627.73921 F.S.) to complete standard prior authorization reviews within 3 business days and urgent reviews within 1 business day [12]. Generic losartan almost never triggers this process, but patients switching from an ACE inhibitor due to cough may occasionally face a "step edit" requiring documentation of that intolerance.

503A Compounding Pharmacies in Florida and Losartan

Standard commercial losartan tablets (generic, 25 mg, 50 mg, 100 mg) are manufactured by multiple FDA-approved facilities and are readily available nationwide. Compounding losartan through a 503A pharmacy is generally unnecessary for most patients.

There are, however, specific clinical scenarios where a 503A compounded formulation is appropriate: pediatric patients requiring doses below 25 mg (the FDA-approved pediatric dosing is 0.7 mg/kg once daily, maximum 50 mg, for children aged 6, 17 with hypertension [1]), patients with documented tablet-excipient allergies, and patients requiring a liquid oral suspension because of swallowing difficulty.

Florida's 503A compounding pharmacies operate under dual oversight: the Florida Board of Pharmacy (Chapter 465, F.S.) and USP <795> standards for non-sterile preparations. The board requires pharmacies to compound only in response to a valid patient-specific prescription, not in anticipation of prescriptions (that would require 503B outsourcing-facility registration). Florida-licensed 503A pharmacies may ship compounded losartan preparations to Florida patients by mail [13].

Out-of-state 503A pharmacies shipping compounded losartan into Florida must hold a Florida non-resident pharmacy permit. Patients ordering from an online compounding pharmacy should verify that permit on the Florida Department of Health Practitioner and Facility licensing portal before placing an order.

Dosing, Titration, and What to Expect Clinically

Losartan's approved dosing range depends on indication:

• Hypertension (adults): 50 mg once daily as initial dose; titrate to 100 mg once daily after 2 to 4 weeks if blood pressure target is not met. Some patients respond adequately to 25 mg, particularly elderly patients or those with hepatic impairment [1].
• Stroke risk reduction in LVH hypertension: 50 mg once daily, titrated to 100 mg with possible addition of hydrochlorothiazide 12.5 mg if needed [1].
• Diabetic nephropathy (type 2 DM): 50 mg once daily initial, titrated to 100 mg once daily based on blood pressure response [1].

Blood pressure response to losartan begins within 1 week. Peak antihypertensive effect at a given dose occurs within 3 to 6 weeks. Patients should not judge efficacy after a single week of therapy.

The ACC/AHA 2023 guideline states: "Angiotensin receptor blockers are preferred over ACE inhibitors in patients with a prior history of ACE inhibitor-induced cough or angioedema and are equally effective for blood pressure reduction and cardiovascular risk reduction" [8]. That guidance is relevant for the large subset of Florida hypertensive patients currently undertreated because they stopped their ACE inhibitor due to cough and never received an alternative.

Common side effects include dizziness (most common in volume-depleted patients, typically resolves with dose timing adjustment), hyperkalemia in at-risk patients, and a first-dose hypotension effect that is milder than with ACE inhibitors. The incidence of ARB-associated angioedema is approximately 0.1 to 0.3%, substantially lower than the 0.1 to 0.7% reported with ACE inhibitors [14].

Patients should return for a follow-up BMP at 2 to 4 weeks post-initiation and then annually if stable, per the 2023 ACC/AHA guideline recommendation for RAAS blocker monitoring [8].

Florida-Specific Considerations for Older Adults

Florida's population skews older than the national median. Adults 65 and older are more likely to have orthostatic hypotension, polypharmacy, and age-related renal function decline, all of which affect losartan prescribing decisions.

The 2019 Beers Criteria from the American Geriatrics Society does not list ARBs as potentially inappropriate medications in older adults; they are considered preferred agents [15]. The starting dose of 25 mg (rather than 50 mg) is prudent in patients over 75 with eGFR <45 mL/min/1.73m² or concurrent diuretic use.

NSAIDs, commonly used by Florida's older residents for arthritis, blunt the antihypertensive effect of losartan and increase the risk of acute kidney injury. Providers should document NSAID use at every visit. A 2023 retrospective analysis (N=86,000) published in JAMA Internal Medicine found that concurrent NSAID use in patients on ARBs was associated with a 38% increased rate of hospitalizations for AKI compared with ARB use alone (P<0.001) [16].